Cardiology
RSSArticles
-
The Removal of Dietary Fructose Improves Pediatric Health
In 43 children with obesity and metabolic syndrome, 9 days of dietary sugar reduction (isocaloric with starch substitution) improved numerous metabolic parameters and led to more than 2 pounds of weight loss.
-
High-intensity Intermittent Training for Type 2 Diabetes Mellitus
High-intensity intermittent training improves cardiac structure and function in addition to reducing liver and visceral fat mass among non-insulin dependent type 2 diabetics.
-
Mediterranean Diet Increases Brain Volume
Higher adherence to the Mediterranean diet led to measurable increases in brain volume in a multi-ethnic sampling of older adults.
-
Prevention of Relapse in Depression: Antidepressants or Mindfulness-based Cognitive Therapy?
Maintenance antidepressants or mindfulness-based cognitive therapy aimed at tapering or discontinuing antidepressants are both effective interventions for prevention of recurrent depression.
-
Does Atrial Fibrillation Portend a Worse Prognosis in the ICU?
In this prospective, observational cohort study, both new-onset and recurrent atrial fibrillation were associated with increased hospital mortality, especially in patients without sepsis.
-
Nutrition in the ICU: The Controversy Continues
When comparing critically ill patients who receive standard enteral feeding vs permissive underfeeding, there is no difference in 90-day mortality.
-
Is Optimizing Respiratory Muscle Function During Mechanical Ventilation an Illusion?
Rapid loss in diaphragmatic thickness during the first week of mechanical ventilation is common and associated with higher levels of ventilator driving pressure.
-
Is Less More Or Is More Less?
ABSTRACT & COMMENTARY: Here are details on oxygen saturation goals in the mechanically ventilated.
-
Reducing Daily Chest Radiographs in the ICU
Quality improvement protocols can reduce the number of chest radiographs in the ICU without compromising care.
-
Left Ventricular Assist Devices for Ambulatory Heart Failure: Weighing the Risks and Benefits
Recent data support the use of the HeartMate II left ventricular assist devices in functionally limited, non-inotrope-dependent heart failure patients who have poor quality of life and meet FDA criteria for destination therapy LVAD.